495 results on '"Hino, Keisuke"'
Search Results
2. New chemiluminescent enzyme immunoassay for quantitative measurement of Mac-2 binding protein glycosylation isomer in chronic liver disease
3. Pancreatic ductal adenocarcinoma with acinar-to-ductal metaplasia-like cancer cells shows increased cellular proliferation
4. Correlation of hepatitis C virus-mediated endoplasmic reticulum stress with autophagic flux impairment and hepatocarcinogenesis
5. Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice
6. Liver Cirrhosis with Inherited Liver Disease: Hemochromatosis
7. Role of Oxidative Stress in Alcoholic/Non-Alcoholic Liver Diseases
8. New quantitative measurement system for M2BPGi reveals liver inflammation complicates liver cirrhosis diagnosis
9. Importance of HBsAg recognition by HLA molecules as revealed by responsiveness to different hepatitis B vaccines
10. Long-term phlebotomy successfully alleviated hepatic iron accumulation in a ferroportin disease patient with a mutation in SLC40A1: a case report
11. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice
12. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial
13. A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial
14. Metal Metabolism and Liver
15. Acyl/free carnitine ratio is a risk factor for hepatic steatosis after pancreatoduodenectomy and total pancreatectomy
16. A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L Trial.
17. Iron and Cancer: A Special Issue
18. HBV with precore and basal core promoter mutations exhibits a high replication phenotype and causes ER stress-mediated cell death in humanized liver chimeric mice
19. A case of protuberant lesion of the gallbladder for which FFT analysis may have been useful in determining benignity
20. A case of intra-abdominal abscess that developed 4 years after pancreatic cancer surgery
21. Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy
22. Inhibition of pancreatic cancer-cell growth and metastasis in vivo by a pyrazole compound characterized as a cell-migration inhibitor by an in vitro chemotaxis assay
23. A case of successful treatment with antiretroviral therapy for HIV in a patient with marked liver dysfunction
24. Hepatitis C Virus Core Protein Suppresses Mitophagy by Interacting with Parkin in the Context of Mitochondrial Depolarization
25. Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma
26. Emergent laparoscopic cholecystectomy for acute acalculous cholecystitis revisited
27. Therapeutic effect of lenvatinib and predictive factor of objective response in patients with unresectable large hepatocellular carcinoma
28. Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid‐enhanced magnetic resonance imaging
29. Different Quasispecies of Hepatitis C Virus in Human Serum, Peripheral Blood Mononuclear Cells, and Liver
30. Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease
31. Genome-wide association study identifies a PSMD3 variant associated with neutropenia in interferon-based therapy for chronic hepatitis C
32. Tu1310: NON-INVASIVE TESTS (NITS) FOR PREDICTING HEPATOCELLULAR CARCINOMA IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTS WITHOUT CIRRHOSIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF INDIVIDUAL PATIENT DATA AND AGGREGATE DATA
33. Transcatheter arterial chemoembolization therapy in combination strategy with lenvatinib in patients with unresectable hepatocellular carcinoma (TACTICS-L) in Japan: Final analysis.
34. CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma
35. Iron and liver cancer: an inseparable connection.
36. # 1076 Sofosbuvir in combination with ribavirin for 12 weeks achieves 97% sustained virologic response in Japanese patients with chronic genotype 2 hepatitis C infection
37. Iron and liver cancer: an inseparable connection
38. Branched-chain amino acids reduce hepatic iron accumulation and oxidative stress in hepatitis C virus polyprotein-expressing mice
39. First jejunal vein oriented mesenteric excision for pancreatoduodenectomy
40. Reduced handgrip strength predicts poorer survival in chronic liver diseases: A large multicenter study in Japan
41. Temperature-Related Effects of Adenosine Triphosphate-Activated Microglia on Pro-Inflammatory Factors
42. Iron metabolic disorder in chronic hepatitis C: insights from recent evidence
43. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open-label, phase 3 trial
44. Separate collection of pancreatic juice using endoscopic naso-pancreatic drainage catheter: O-093
45. Hepatic oxidative stress in ovariectomized transgenic mice expressing the hepatitis C virus polyprotein is augmented through suppression of adenosine monophosphate-activated protein kinase/proliferator-activated receptor gamma co-activator 1 alpha signaling
46. Mitochondrial reactive oxygen species as a mystery voice in hepatitis C
47. Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma.
48. Clinical usefulness of non-protein respiratory quotient measurement in non-alcoholic fatty liver disease
49. Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species
50. Serum miR-379 expression is related to the development and progression of hypercholesterolemia in non-alcoholic fatty liver disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.